Group One Trading, L.P. Cassava Sciences Inc Transaction History
Group One Trading, L.P.
- $2.4 Billion
- Q3 2024
A detailed history of Group One Trading, L.P. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 130,789 shares of SAVA stock, worth $3.41 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
130,789Holding current value
$3.41 Million% of portfolio
0.16%Shares
15 transactions
Others Institutions Holding SAVA
# of Institutions
207Shares Held
14MCall Options Held
2.98MPut Options Held
6.57M-
Black Rock Inc. New York, NY3.22MShares$83.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$65.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$30.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$26.3 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO580KShares$15.1 Million7.83% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $1.04B
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...